Specialist
C-level executive at Olaplex Inc
Agenda
- Key trends and developments in the North American beauty industry
- Demand trends across key segments, channels and geographies
- 12-18-month outlook
Questions
1.
What are your top-of-mind expectations for the beauty industry in 2021?
2.
What is your overall expectation for a sales recovery in 2021 compared to 2020? How are you thinking about beauty sales on a QoQ basis? What do you think 2021 will be like relative to 2019?
3.
You mentioned eye make-up becoming the new lipstick. What else is there to be said about health trends or clean ingredients driving beauty sales in the year ahead? How much penetration is there for natural or clean ingredient beauty products?
4.
Considering the mix shift from the bricks-and-mortar channel and speciality retail into e-commerce, what are your expectations for that mix in 2021? Are there any significant channel mix shifts that you think are going to be permanent?
5.
Are the consumption trends among generation Z and millennials different from older generations in the fragrance category? Are younger generations less interested in fragrances?
6.
What are your thoughts on the potential of e-commerce fragrance options such as Scentbird?
7.
Based on November, December, and the seasonality of the category itself, what sorts of gains do you expect for fragrances in 2021, if any?
8.
Data suggests there was some strain on in-store mass-market beauty. What are your observations on this channel’s dynamics? What is your outlook for in-store mass-market beauty in 2021?
9.
You mentioned Ulta’s move into Target and then there’s also Sephora’s move into Kohl’s. Which of these players do you think is better positioned, and how do you expect the strategic landscape to change with speciality retailers moving into the mass channel, or having those partnerships set up?
10.
Who do you think are the major winners and losers in mass colour at players such as Walmart, Target, Ulta and Sephora? Has there been any feedback from buyers on the shelf shifts?
11.
The mass colour cosmetics category has been weak for several years. What is your recovery outlook for 2021? How have the behavioural changes during the pandemic changed your outlook for mass colour in the near and longer term? Are there any key innovations that can drive category growth again?
12.
How are Revlon and Coty positioned for a post-coronavirus world?
13.
Do you expect Revlon to monetise any assets, such as Arden or Crew? If so, do any specific ones come to mind, and do you have any thoughts around valuations for them?
14.
Do any potential buyers for Revlon come to mind?
15.
Do you have reason to believe that the weakness in mass colour cosmetics is cyclical, due to lack of new innovation, or structural, given more focus on skincare?
16.
Elf has outperformed relative to the broader category, but what do you think are the main contributing factors, and do you think this trend will continue? Do the management changes at Coty and CoverGirl change Elf’s ability to gain significant market share?
17.
What is your opinion on the Keys Soulcare brand, endorsed by Alicia Keys, and Elf’s ability to grow multiple brands aside from this one?
18.
What is the typical distribution of sales for celebrity brand launches in the first year? How should we evaluate the Keys Soulcare line relative to that?
19.
With speciality beauty retailers such as a Sephora and Ulta rapidly growing their e-commerce businesses, are there any implications for larger vs smaller beauty brands longer-term?
20.
Does the recent news of the Democratic Senate change your outlook? Do you expect further lockdowns? How might that impact the beauty industry overall?
21.
Do you have any closing remarks? Is there anything we may not have done justice to over the course of the Interview?
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary 48 hour week trial
The information, material and content contained in this transcript (“Content”) is for information purposes only and does not constitute advice of any type or a trade recommendation and should not form the basis of any investment decision.This transcript has been edited by Third Bridge for ease of reading. Third Bridge Group Limited and its affiliates (together “Third Bridge”) make no representation and accept no liability for the Contentor for any errors, omissions or inaccuracies in respect of it. The views of the specialist expressed in the Content are those of the specialist and they are not endorsed by, nor do they represent the opinion of, Third Bridge. Third Bridge reserves all copyright, intellectual and other property rights in the Content. Any modification, reformatting, copying, displaying, distributing, transmitting, publishing, licensing, creating derivative works from, transferring or selling any Content is strictly prohibited
